PWA
TXG icon

Physician Wealth Advisors’s 10x Genomics TXG Stock Holding History

Physician Wealth Advisors’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.6K Buy
302
+42
+16% +$1.1K ﹤0.01% 829
2026
Q1 		$5.52K Hold
260
– – ﹤0.01% 974
2025
Q4 		$4.24K Hold
260
– – ﹤0.01% 1025
2025
Q3 		$3.04K Hold
260
– – ﹤0.01% 1064
2025
Q2 		$3.01K Buy
260
+206
+381% +$1.88K ﹤0.01% 914
2025
Q1 		$472 Buy
+54
New +$681 ﹤0.01% 1369

Other funds holding TXG

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CG
Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return
FC
Financial Consulate Hunt Valley, Maryland $899M AUM 20.23% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return

Physician Wealth Advisors's TXG Position: Q2 2026 in Review

Physician Wealth Advisors increased its 10x Genomics (TXG) stake by 16% in Q2 2026, buying an estimated $1.1K and bringing the position to 302 shares worth $11.6K. The position accounts for ﹤0.01% of the portfolio, ranked #829.

Physician Wealth Advisors first reported a position in TXG in Q1 2025 and has held it in 6 quarters since. 114 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Physician Wealth Advisors held 302 shares of 10x Genomics worth $11.6K as of Q2 2026.
  • Physician Wealth Advisors bought 42 10x Genomics shares in Q2 2026, an estimated $1.1K.
  • 10x Genomics made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #829 holding.
  • Physician Wealth Advisors first reported a position in 10x Genomics in Q1 2025 and has held it in 6 quarters since.
  • 114 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.